GSK boosted to 90% electronical invoice processing
GlaxoSmithKline plc (GSK) is one of the world’s largest pharmaceutical, biological, and healthcare companies.
In 2014, GSK was processing ~60% of its invoices electronically via Tungsten Network. Following a huge internal effort, working in concert with Tungsten, GSK was able to drive up processing volumes while driving down the cost, benefitting from Tungsten’s global coverage and ability to deliver invoices that comply with international tax regulations.
“We recognised that electronic invoicing could be a complementary way of increasing levels of automation. Many of our suppliers were already on the Tungsten Network platform, which helped us validate the technical solution.” – Jens Fischer, Global Process Manager, GlaxoSmithKline